Back

Mechanical thrombectomy is associated with worse outcomes in infective endocarditis: a retrospective cohort study

31 August 2024 (11:00 - 11:50)
Organised by: Logo
Congress Presentation Part of: Management of infective endocarditis: the good and the bad Treatment ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Raphae Barlas

University of Aberdeen, Aberdeen (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
Oral step-down antibiotic treatment in patients with prosthetic valve endocarditis; a POETry substudy
Doctor M. Pries-Heje (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Changes in length of hospital stay for infective endocarditis - data from before and after the POET trial
Doctor L. Ostergaard (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Relapse of infective endocarditis after cardiac implantable electronic device removal compared to a conservative strategy
Doctor A. Alhakak (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Long-term follow-up after infective endocarditis: comparison of patients who have undergone cardiac surgery versus a conservative therapy with and without an indication for cardiac surgery
Miss E. Taner (Ludwigshafen am Rhein, DE)
Abstract Slides Video
Presentation thumbnail
Relative contribution of imaging techniques for the contemporary diagnosis of infective endocarditis: a single-center experience
Doctor R. Barbosa Sousa (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Management of infective endocarditis: the good and the bad

The Event

Event poster

ESC Congress 2024

31 August 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Association of anticoagulation with outcomes in patients with infective endocarditis
thumbnail
Congress Session
Managing infective endocarditis: guidelines and beyond
thumbnail
Congress Presentation
Acute ischemic stroke complicating tavi. predictors, outcomes, and treatment associated outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources